Delivery Order SPE2DB22D3016-SPE2DB24FBDL9

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a firm fixed price of $16,648.10 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron orally disintegrating tablets in 30-count packages. The $1,825 firm-fixed-price contract has an ultimate completion date of April 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which enables efficient procurement of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,481,629 units of the 8 mg Ondansetron orally disintegrating tablet in 30-count packages. The firm-fixed-price contract, valued at $3,182.49, has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron orally disintegrating tablets. The contract has a ceiling value of $3,222.53 and an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $2,386.49 firm fixed price contract is for the supply of 30-count packages of 8 mg ondansetron orally disintegrating tablets. This delivery order is part of a larger IDC valued at up to $999,999,999 through December 2025 that enables DLA to efficiently procure a comprehensive range of medical...
This is a firm-fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $11,513.11, is for the delivery of 4,565 units of 30-count packages of 4 mg Ondansetron orally disintegrating tablets. The contract has a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has a firm fixed price of $1,539.86 and a completion date of February 20, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages, with a total ceiling value of $8,607.73 and a completion date of November 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.40 firm fixed-price contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The ultimate completion date is February 7, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,093,137 units of Ondansetron ODT 4 mg tablets, with a firm fixed price ceiling value of $2,158.78. The contract has an ultimate completion date of May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBDL9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4 milligram Ondansetron orally disintegrating tablets in 30-count packages. The $2,715.52 firm-fixed-price contract has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/8/24, 9:23 AM